Published in Transplant Proc on December 01, 1996
Tumor growth effects of rapamycin on human biliary tract cancer cells. Eur J Med Res (2012) 0.76
The incidence and risk factors of de novo skin cancer in the liver transplant recipients. Int J Organ Transplant Med (2012) 0.75
OX VITREOUS HUMOUR. 1.-THE RESIDUAL PROTEIN. Br J Ophthalmol (1948) 7.46
THE SYNTHESIS OF A POLYSACCHARIDE FROM GLUCOSE-1-PHOSPHATE IN MUSCLE EXTRACT. Science (1939) 7.02
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
Hyperthermia in combined treatment of cancer. Lancet Oncol (2002) 4.41
Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun (1985) 3.58
Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54
Intestinal colonization and virulence of Salmonella in mice. Infect Immun (1978) 3.44
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology (2001) 3.26
Retracted Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy. Br J Surg (2005) 3.06
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics (2001) 3.05
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
Immunochemistry of R lipopolysaccharides of Escherichia coli. Different core regions in the lipopolysaccharides of O group 8. Eur J Biochem (1969) 2.89
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res (1996) 2.86
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem (1999) 2.78
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Activities, events and outcomes in ambulatory patient care. N Engl J Med (1969) 2.63
GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol (2000) 2.56
Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant (2011) 2.54
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut (2003) 2.39
Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res (1996) 2.35
Sexual segregation in ungulates: a comparative test of three hypotheses. Biol Rev Camb Philos Soc (2002) 2.34
Immunochemical studies on core lipopolysaccharides of Enterobacteriaceae of different genera. Eur J Biochem (1970) 2.29
Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun (1999) 2.26
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
The genetic determinants of the CYP3A5 polymorphism. Pharmacogenetics (2001) 2.21
Immunochemistry of R lipopolysaccharides of Escherichia coli. Studies on R mutants with an incomplete core, derived from E. coli O8:K27. Eur J Biochem (1970) 2.18
The impact of carbon dioxide pneumoperitoneum on liver regeneration after liver resection in a rat model. Surg Endosc (2009) 2.16
Escherichia coli adhesion to Saccharomyces cerevisiae and mammalian cells: role of piliation and surface hydrophobicity. Infect Immun (1981) 2.09
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Chemistry and biology of the enterobacterial common antigen (ECA). Curr Top Microbiol Immunol (1979) 1.99
The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord (2000) 1.99
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology (1998) 1.98
Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy. J Hepatol (2010) 1.95
Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum (2000) 1.95
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology (1996) 1.86
Management and outcome of patients with combined bile duct and hepatic arterial injuries after laparoscopic cholecystectomy. Surgery (2004) 1.82
Characterization of pili associated with Escherichia coli O18ac. Infect Immun (1980) 1.80
Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun (2000) 1.78
Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg (2008) 1.74
Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. J Biol Chem (1998) 1.73
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J Cell Biol (1987) 1.68
Rho GTPases as targets of bacterial protein toxins. Biol Chem (2000) 1.68
Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia (1998) 1.67
Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: results of a prospective randomized trial. Am J Transplant (2008) 1.67
Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperthermia (1997) 1.66
The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol (1999) 1.66
Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest (1990) 1.64
C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant (2006) 1.62
Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial. Eur Radiol (2001) 1.60
Hepatocellular carcinoma in association with hepatic focal nodular hyperplasia. Acta Radiol (2006) 1.59
On a bacteriophage T3 and T4 receptor region within the cell wall lipopolysaccharide of Escherichia coli B. J Mol Biol (1976) 1.57
Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) (2003) 1.56
Application of the Woman Abuse Screening Tool (WAST) and WAST-short in the family practice setting. J Fam Pract (2000) 1.56
Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol (2001) 1.55
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. Radiology (1997) 1.52
The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem (2001) 1.52
Radical resection and liver grafting as the two main components of surgical strategy in the treatment of proximal bile duct cancer. World J Surg (1988) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
Small-angle neutron scattering study of lateral phase separation in dimyristoylphosphatidylcholine-cholesterol mixed membranes. Biochemistry (1985) 1.51
Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50
Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology (1998) 1.49
Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology (2000) 1.48
A clinical pilot study of fresh frozen plasma versus human albumin in paediatric craniofacial repair. J Int Med Res (2008) 1.48
Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int (1996) 1.47
Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis (2007) 1.47
The laparoscopic Janeway gastrostomy. An alternative technique when percutaneous endoscopic gastrostomy is impractical. Endoscopy (2001) 1.46
Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol (2005) 1.46
Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy. Br J Surg (2011) 1.46
Bacterial protein toxins targeting rho GTPases. FEMS Microbiol Lett (2000) 1.46
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Tunneling anisotropic magnetoresistance: a spin-valve-like tunnel magnetoresistance using a single magnetic layer. Phys Rev Lett (2004) 1.45
Experiences with liver transplantation in Hannover. Hepatology (1984) 1.45
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist. Transplantation (1999) 1.43
Venous complications after orthotopic liver transplantation. Clin Transplant (2000) 1.43
[Hemagglutinins against a common enterobacteriaceae antigen in E. coli R1-antisera]. Zentralbl Bakteriol Orig (1971) 1.42
[Morphologic studies of the placentas of HIV-positive mothers]. Pathologe (1988) 1.41
Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity? Br J Dermatol (2013) 1.40
Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg (2001) 1.40
Diagnosis of enteroceles by dynamic anorectal endosonography. Dis Colon Rectum (2000) 1.40
Effect of medial displacement calcaneal osteotomy on ankle kinematics in a cadaver model. Foot Ankle Int (1998) 1.39
[Simulation of a colon carcinoma: diuretic-induced ulcerative-stricturing ischemic colitis]. Dtsch Med Wochenschr (2004) 1.39
THE EFFECT OF NUCLEOPHOSPHATASE ON "NATIVE" AND DEPOLYMERIZED THYMONUCLEIC ACID. Science (1938) 1.39
Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation (2001) 1.38
Donor criteria in hepatic transplantation. Langenbecks Arch Chir (1994) 1.38
[Diagnostic and therapeutic management of patients receiving antithrombotic drugs: what to heed?]. Dtsch Med Wochenschr (2006) 1.38
[Mesenteric artery occlusion as a rare complication of thromboangiitis obliterans]. Chirurg (2002) 1.38